H. pylori treatment in a resistant world: Regional strategies for effective eradication: A narrative review
Abstract
The transmission of Helicobacter pylori (H. pylori) is still a major global health concern. As antibiotic resistance increases, the efficacy of traditional treatment plans—which are mostly dependent on proton pump inhibitors and antibiotics—is being gradually undermined. This review examines the regional variations in H. pylori treatment guidelines, shaped by local resistance patterns, healthcare infrastructure, and available therapies. In regions with high resistance, such as South Asia, bismuth quadruple therapy has become the preferred first-line option, offering higher eradication rates. In contrast, countries like Japan and South Korea have seen improved outcomes with the introduction of potassium-competitive acid blockers (P-CABs) and high dose amoxicillin-based regimens respectively. These regional disparities highlight the significance of tailoring H. pylori treatment to local resistance trends in order to tackle the growing threat of antibiotic resistance. The purpose of this review is to investigate geographical variations in Helicobacter pylori antibiotic resistance patterns and their impact on treatment methods. By highlighting how resistance trends impact therapeutic outcomes, this review seeks to guide clinicians in selecting the most effective, region-specific therapies for H. pylori eradication. Additionally, it underscores the critical need for ongoing research to better understand resistance dynamics and inform updated treatment guidelines, ensuring…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.